Trinity Biotech Total Liabilities and Share Holders Equity 2010-2024 | TRIB

Trinity Biotech total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Trinity Biotech Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $59
2022 $92
2021 $119
2020 $130
2019 $131
2018 $152
2017 $193
2016 $250
2015 $364
2014 $243
2013 $226
2012 $197
2011 $171
2010 $161
2009 $132
Trinity Biotech Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $97
2024-06-30 $94
2024-03-31 $90
2023-12-31 $59
2023-09-30 $64
2023-06-30 $72
2023-03-31 $91
2022-12-31 $92
2022-09-30 $98
2022-06-30 $107
2022-03-31 $106
2021-12-31 $119
2021-09-30 $123
2021-06-30 $125
2021-03-31 $136
2020-12-31 $130
2020-09-30 $136
2020-06-30 $129
2020-03-31 $129
2019-12-31 $131
2019-09-30 $173
2019-06-30 $172
2019-03-31 $173
2018-12-31 $152
2018-09-30 $183
2018-06-30 $194
2018-03-31 $195
2017-12-31 $193
2017-09-30 $245
2017-06-30 $245
2017-03-31 $245
2016-12-31 $250
2016-09-30 $360
2016-06-30 $358
2016-03-31 $360
2015-12-31 $364
2015-09-30 $355
2015-06-30 $360
2015-03-31 $247
2014-12-31 $243
2014-09-30 $237
2014-06-30 $238
2014-03-31 $229
2013-12-31 $226
2013-09-30 $223
2013-06-30 $203
2013-03-31 $203
2012-12-31 $197
2012-09-30 $190
2012-06-30 $184
2012-03-31 $182
2011-12-31 $171
2011-09-30 $170
2011-06-30 $168
2011-03-31 $166
2010-12-31 $161
2010-09-30 $158
2010-06-30 $153
2010-03-31 $132
2009-12-31 $132
2009-09-30 $130
2009-06-30 $131
2009-03-31 $125
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.015B $0.057B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.085B 27.79
Boston Scientific (BSX) United States $155.238B 38.86
Stryker (SYK) United States $144.362B 30.18
EssilorLuxottica (ESLOY) France $132.860B 0.00
Medtronic (MDT) Ireland $108.824B 15.89
Lonza Group Ag (LZAGY) Switzerland $52.624B 0.00
Haleon (HLN) United Kingdom $48.259B 27.44
ResMed (RMD) United States $35.183B 26.43
GE HealthCare Technologies (GEHC) United States $32.295B 15.33
Agilent Technologies (A) United States $30.971B 20.46
Terumo (TRUMY) Japan $29.019B 0.00
Koninklijke Philips (PHG) Netherlands $24.053B 17.17
Zimmer Biomet Holdings (ZBH) United States $20.255B 12.80
Insulet (PODD) United States $18.084B 77.18
Baxter (BAX) United States $15.752B 11.77
Smith & Nephew SNATS (SNN) United Kingdom $12.535B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $7.970B 0.00
Lantheus Holdings (LNTH) United States $7.447B 18.31
Bio-Rad Laboratories (BIO) United States $6.620B 22.38
Prestige Consumer Healthcare (PBH) United States $4.171B 19.90
Perrigo (PRGO) Ireland $3.497B 10.01
ICU Medical (ICUI) United States $3.486B 29.69
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.208B 15.10
Envista Holdings (NVST) United States $2.880B 23.93
GN Store Nord (GNNDY) Denmark $2.068B 17.13
QuidelOrtho (QDEL) United States $1.964B 16.45
LeMaitre Vascular (LMAT) United States $1.778B 39.75
AtriCure (ATRC) United States $1.486B 0.00
Green Thumb Industries (GTBIF) United States $1.374B 21.63
Neogen (NEOG) United States $1.248B 15.97
Kestra Medical Technologies (KMTS) United States $1.220B 0.00
BioLife Solutions (BLFS) United States $1.200B 0.00
AdaptHealth (AHCO) United States $1.184B 11.40
InMode (INMD) Israel $1.013B 9.28
Phibro Animal Health (PAHC) United States $0.789B 12.10
Evolus (EOLS) United States $0.779B 0.00
Curaleaf Holdings (CURLF) Canada $0.637B 0.00
CeriBell (CBLL) United States $0.588B 0.00
Owens & Minor (OMI) United States $0.580B 4.94
Valneva SE (VALN) France $0.549B 0.00
Capricor Therapeutics (CAPR) United States $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.526B 0.00
Tilray Brands (TLRY) Canada $0.458B 0.00
Cresco Labs (CRLBF) United States $0.442B 0.00
Omeros (OMER) United States $0.418B 0.00
Surmodics (SRDX) United States $0.395B 0.00
SNDL (SNDL) Canada $0.365B 0.00
VAREX IMAGING (VREX) United States $0.359B 15.55
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Verano Holdings (VRNOF) United States $0.296B 0.00
Sanara MedTech (SMTI) United States $0.292B 0.00
Viemed Healthcare (VMD) United States $0.291B 26.32
Aurora Cannabis (ACB) Canada $0.272B 48.40
Sanuwave Health (SNWV) United States $0.264B 0.00
ZimVie (ZIMV) United States $0.261B 15.60
Cerus (CERS) United States $0.258B 0.00
Canopy Growth (CGC) Canada $0.245B 0.00
Quanterix (QTRX) United States $0.233B 0.00
OraSure Technologies (OSUR) United States $0.231B 0.00
High Tide (HITI) Canada $0.194B 0.00
Biote (BTMD) United States $0.190B 4.35
Utah Medical Products (UTMD) United States $0.173B 13.93
Brainsway (BWAY) Israel $0.170B 53.06
TriSalus Life Sciences (TLSI) United States $0.165B 0.00
Organigram Global (OGI) Canada $0.154B 0.00
FitLife Brands (FTLF) United States $0.148B 18.22
Jin Medical (ZJYL) China $0.119B 0.00
TerrAscend (TSNDF) Canada $0.116B 0.00
MacroGenics (MGNX) United States $0.110B 0.00
Exagen (XGN) United States $0.108B 0.00
Agape ATP (ATPC) $0.099B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Fonar (FONR) United States $0.076B 10.70
Jushi Holdings (JUSHF) United States $0.076B 0.00
Veru (VERU) United States $0.075B 0.00
InterCure (INCR) Israel $0.073B 0.00
Zynex (ZYXI) United States $0.070B 0.00
United Health Products (UEEC) United States $0.064B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Apyx Medical (APYX) United States $0.047B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Rockwell Medical (RMTI) United States $0.042B 61.50
United-Guardian (UG) United States $0.037B 11.28
Safety Shot (SHOT) United States $0.036B 0.00
Nephros (NEPH) United States $0.020B 0.00
INLIF (INLF) $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Allurion Technologies (ALUR) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Senestech (SNES) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00